Abstract:The thyroid-stimulating hormone receptor (TSHR) is a member of the glycoprotein hormone receptors, a sub-group of class A G-protein-coupled receptors (GPCRs). TSHR and its endogenous ligand thyrotropin (TSH) are of essential importance for growth and function of the thyroid gland and proper function of the TSH/TSHR system is pivotal for production and release of thyroid hormones. This receptor is also important with respect to pathophysiology, such as autoimmune (including ophthalmopathy) or non-autoimmune thyroid dysfunctions and cancer development. Pharmacological interventions directly targeting the TSHR should provide benefits to disease treatment compared to currently available therapies of dysfunctions associated with the TSHR or the thyroid gland. Upon TSHR activation, the molecular events conveying conformational changes from the extra- to the intracellular side of the cell across the membrane comprise reception, conversion, and amplification of the signal. These steps are highly dependent on structural features of this receptor and its intermolecular interaction partners, e.g., TSH, antibodies, small molecules, G-proteins, or arrestin. For better understanding of signal transduction, pathogenic mechanisms such as autoantibody action and mutational modifications or for developing new pharmacological strategies, it is essential to combine available structural data with functional information to generate homology models of the entire receptor. Although so far these insights are fragmental, in the past few decades essential contributions have been made to investigate in-depth the involved determinants, such as by structure determination <i>via</i> X-ray crystallography. This review summarizes available knowledge (as of December 2016) concerning the TSHR protein structure, associated functional aspects, and based on these insights we suggest several receptor complex models. Moreover, distinct TSHR properties will be highlighted in comparison to other class A GPCRs to understand the molecular activation mechanisms of this receptor comprehensively. Finally, limitations of current knowledge and lack of information are discussed highlighting the need for intensified efforts toward TSHR structure elucidation.

A study of animal companionship in a day hospice

Single Hormone or Synthetic Agonist Induces G S /G I Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths

Structure and dynamics determine G protein coupling specificity at a class A GPCR

Development of a read out driver for ATLAS micromegas based on the Scalable Readout System

Structural–Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Division of labour and sex differences between fibrillar, tarsal adhesive pads in beetles: effective elastic modulus and attachment performance

Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor

GPCRs steer G<sub>i</sub> and G<sub>s</sub> selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors

Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor

Structural features of the G-protein/GPCR interactions

Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Common coupling map advances GPCR-G protein selectivity

Multiple triggers converge to preferential effector coupling in the CB R through a complex allosteric communication network

Molecular basis for the selective G protein signaling of somatostatin receptors

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

G-protein activation by a metabotropic glutamate receptor

Structural basis for GPCR-independent activation of heterotrimeric Gi proteins

Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II

Exploring human rare disease variants from a multidimensional perspective illuminates receptor – G protein coupling diversity